IQVIA Announces Offering of Senior Notes
IQVIA plans to raise $2 billion via senior notes due 2034, intending to use proceeds to redeem existing debt and repay revolving credit facility obligations.
See the latest news and media coverage for IQVIA. We track all announcements, press releases, and industry mentions in real time, all in one place.
Life sciences data, technology, analytics, and services provider
iqvia.comLast updated
In short: IQVIA reported strong 2026 financial results, expanded its AI-driven platforms, and increased its share repurchase program by $2 billion.
IQVIA plans to raise $2 billion via senior notes due 2034, intending to use proceeds to redeem existing debt and repay revolving credit facility obligations.
Revenue reached $4.368 billion, with adjusted EBITDA up 9.2% and raised full-year guidance.
Dr. Cynthia Verst testified before a House subcommittee, highlighting opportunities to modernize early clinical development while maintaining FDA standards.
The company will host a conference call and webcast at 9:00 a.m. ET, and the earnings release will be posted on the IR website.
RESEARCH TRIANGLE PARK, N.C. -- (BUSINESS WIRE)--Sep. 9, 2026-- ...
Earlier in the current quarter, IQVIA Holdings reported second-quarter results that topped earnings expectations, with adjusted earnings rising 12.1% year over year and revenue increasing...
IQVIA Holdings stock hovers in the low $240s as of mid-August 2026, with a market value above $39 billion and recent quarterly earnings showing a...
IQVIA Holdings Inc. IQV stock has rallied over the past three months. The company's shares have jumped 41.5%, outperforming the industry's 17.2% growth and the...
Track IQVIA and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to IQVIA and other trending companies.